This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Beijing Jiaotong University, Beijing Zhifei Lvzhu Biopharmaceutical Co. Ltd. Active years: 2025.
Company Filing History:
1 out of 64 
1 out of 1 Years Active: 2025
Title: Xianglei Peng: Innovator in Vaccine Development
Introduction
Xianglei Peng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in vaccine development. His work focuses on combating respiratory infections, which are a major health concern worldwide.
Latest Patents
One of Xianglei Peng's notable patents is titled "Combined Vaccine Against Human Respiratory Syncytial Virus (RSV) Infections and Method Thereof for Inducing Immune Response." This patent highlights his innovative approach to enhancing immune responses against RSV, a virus that poses serious risks, especially to infants and the elderly. He holds 1 patent in this area.
Career Highlights
Throughout his career, Xianglei Peng has worked with reputable organizations, including Beijing Zhifei Lvzhu Biopharmaceutical Co. Ltd and Beijing Jiaotong University. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Xianglei Peng has collaborated with notable colleagues such as Jinsheng He and Weihua Zhu. These partnerships have been instrumental in advancing his research and developing effective solutions for public health challenges.
Conclusion
In summary, Xianglei Peng is a dedicated inventor whose work in vaccine development is making a significant impact on global health. His innovative approaches and collaborations continue to pave the way for advancements in biopharmaceuticals.